Capsaicin on Salty Gustatory Cortices

January 7, 2016 updated by: Zhiming Zhu

Effects of Capsaicin on Salty Gustatory Cortices in Human

Excess dietary salt intake is closely associated with the development of hypertension and cardiocerebral vascular diseases. Preference of high salt diet might involve salty gustatory cortices change. This study focuses on examining the neuroimaging changes of salty gustatory cortices under different concentration of NaCl solution with or without capsaicin intervention through brain PET/CT scan.

Study Overview

Status

Completed

Conditions

Detailed Description

Hypertension and its related complications are common health problems that can lead to multiple organ damage and death. Excessive salt intake plays an important role in the development of hypertension.

The experimental design is a randomized, double-blind, interventional study to investigate the neuroimaging changes of salty gustatory cortices under different concentration of NaCl solution with or without capsaicin intervention through brain PET/CT scan.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Chongqing
      • Chongqing, Chongqing, China, 400042
        • Daping Hospital, The Third Military Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 18 years and ≤ 65 years.
  • Willing and able to provide written informed consent.
  • Willing and able to comply with all study procedures.

Exclusion Criteria:

  • High basic metabolic rate, tumor, epilepsia.
  • Hypogeusia or loss due to neural system disease or oral and digestive disease.
  • Capsaicin allergy and poor compliance.
  • Recently oral diuretics and participate in other pharmacological experiment in 3 months.
  • Acute infection, cancer, serious arrhythmias, drug or alcohol abuse.
  • Currently have cold, fever, acidosis, dehydration, diarrhea, vomiting during the study.
  • Unwilling or unable to communication due to the dysnoesia and language disorders.
  • Severe neural or psychiatric diseases that would preclude fully understand and corporation in the study.
  • History of allergic reaction attributed to 18F-FDG.
  • Pregnancy or lactation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Capsaicin_effect subgroup 1
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of water with capsaicin.
Capsaicin in the concentration of 0.5 µmol/L was mixed in the test solutions in Capsaicin_effect subgroups
Experimental: Capsaicin_effect subgroup 2
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 100 mmol/L NaCl with capsaicin.
Capsaicin in the concentration of 0.5 µmol/L was mixed in the test solutions in Capsaicin_effect subgroups
Experimental: Capsaicin_effect subgroup 3
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 150 mmol/L NaCl with capsaicin.
Capsaicin in the concentration of 0.5 µmol/L was mixed in the test solutions in Capsaicin_effect subgroups
No Intervention: Capsaicin_effect subgroup 4
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 200 mmol/L NaCl.
No Intervention: Salt_effect subgroup 1
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of water.
Experimental: Salt_effect subgroup 2
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 100 mmol/L NaCl.
NaCl in various concentrations was desorved in the test solutions in Salt_effect subgroups
Experimental: Salt_effect subgroup 3
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 150 mmol/L NaCl.
NaCl in various concentrations was desorved in the test solutions in Salt_effect subgroups
Experimental: Salt_effect subgroup 4
The volunteers allocated to the arm will perform neuroimaging detection with buccal administration of 200 mmol/L NaCl.
NaCl in various concentrations was desorved in the test solutions in Salt_effect subgroups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuroimaging changes of salty gustatory cortices
Time Frame: 45min
Buccal administration of test solution for five mins, and PET/CT scan after 40 mins
45min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

October 27, 2013

First Submitted That Met QC Criteria

October 27, 2013

First Posted (Estimate)

November 1, 2013

Study Record Updates

Last Update Posted (Estimate)

January 11, 2016

Last Update Submitted That Met QC Criteria

January 7, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Volunteers

Clinical Trials on Capsaicin

3
Subscribe